Carol Webb Citius Pharmaceuticals, Inc. (CTXR) insider trading activity

CTXR Quotes by TradingView

Carol Webb is Director of Citius Pharmaceuticals, Inc.. Currently has a direct ownership of 11,835 shares of CTXR, which is worth approximately $4,260. The most recent transaction as insider was on Mar 04, 2024, when has been sold 236 shares (Common Stock) at a price of $0.77 per share, resulting in proceeds of $181. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 11.8K
0% 3M change
n/a 12M change
Total Value Held $4,260

Carol Webb Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 04 2024
SELL
Payment of exercise price or tax liability
$181 $0.77 p/Share
236 Reduced 1.96%
11,835 Common Stock
Mar 04 2024
BUY
Exercise of conversion of derivative security
$241 $0.02 p/Share
12,071 Added 50.0%
12,071 Common Stock

Also insider at

TENK
TenX Keane Acquisition
Director
CW

Carol Webb

Director
Cranford, NJ

Track Institutional and Insider Activities on CTXR

Follow Citius Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CTXR shares.

Notify only if

Insider Trading

Get notified when an Citius Pharmaceuticals, Inc. insider buys or sells CTXR shares.

Notify only if

News

Receive news related to Citius Pharmaceuticals, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CTXR